BusinessExosome Diagnostics Announces Publication of a Highly Sensitive Exosome Based Liquid Biopsy Test for EGFR T790M Mutations in Plasma from Non-Small Cell Lung Cancer PatientsBy Nasdaq OMXMar 20, 2018, 11:46 AM UTC
BusinessPrecipio Launches Unique Lung Cancer Monitoring Test for Therapy ResistanceBy Nasdaq OMXFeb 15, 2018, 1:38 PM UTC
BusinessLeading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung CancerBy Nasdaq OMXJan 23, 2018, 7:15 PM UTC
BusinessExosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung CancerBy Nasdaq OMXDec 19, 2017, 12:51 PM UTC
BusinessGlobal Lung Cancer Awareness Month Coalition Kicks-Off 2017 Awareness MonthBy Nasdaq OMXNov 6, 2017, 8:13 PM UTC
BusinessNew Study Reports Favorable Results for Intuitive Surgical’s Flexible Robotics PlatformBy Nasdaq OMXNov 2, 2017, 1:00 PM UTC
BusinessVaccinex, Inc. Announces the First Patient Treated in a Phase Ib/II Combination Study with Anti-Semaphorin 4D Antibody, VX15/2503, and Avelumab in Non-Small Cell Lung Cancer Patients (CLASSICAL – Lung)By Nasdaq OMXOct 26, 2017, 2:23 PM UTC
